Related Experiment Video
Updated: Aug 8, 2026

07:54
Cholesterol Efflux Assay
Published on: March 6, 2012
Variability gene effect on cholesterol at the Kidd blood group locus
1Institute of Medical Genetics, Univesity of Oslo, Norway.
Clinical Genetics
|February 1, 1988
Summary
The Kidd Jkb gene may restrict total cholesterol variability in identical twins, influencing coronary heart disease risk. This study explored gene-environment interactions in lipid levels.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Biochemistry
Background:
- Understanding genetic influences on lipid levels is crucial for assessing coronary heart disease (CHD) risk.
- Monozygotic (MZ) twins provide a unique model to study gene-environment interactions due to their identical genetic makeup.
- The Kidd blood group system, specifically the Jka and Jkb antigens, has been investigated for potential associations with various health parameters.
Purpose of the Study:
- To investigate the influence of Kidd blood group genotypes on lipid level variability within monozygotic twin pairs.
- To explore the potential role of specific Kidd alleles in modulating total cholesterol, triglyceride, and HDL cholesterol variability.
- To further validate the "variability gene" concept in the context of gene-environment interactions and CHD risk.
Main Methods:
- Analysis of serum lipid levels (total cholesterol, triglycerides, HDL cholesterol) in 142 monozygotic twin pairs from the Norwegian Twin Panel.
- Comparison of within-pair lipid level differences based on Kidd blood group genotypes (heterozygous for Kidd genes, homozygous for Jkb, homozygous for Jka).
- Statistical analysis to determine the significance of observed differences and associations, controlling for sex and age.
Main Results:
- A significantly lower mean within-pair difference in total cholesterol was observed in MZ pairs heterozygous for Kidd genes or homozygous for Jkb, compared to those homozygous for Jka.
- The Jkb gene appears to have a restrictive effect on total cholesterol variability.
- No significant effects of Kidd blood groups on triglyceride or HDL cholesterol variability were detected, nor were associations found with absolute lipid levels.
Conclusions:
- The Kidd Jkb gene may act as a "variability gene," influencing the environmental modulation of total cholesterol levels.
- This finding supports the concept that individual coronary heart disease risk is a complex interplay of "level genes," "variability genes," and lifestyle factors.
- The study confirms the utility of MZ twin variability studies for dissecting gene-environment interactions impacting complex traits.
Related Concept Videos
Genetic Lingo
Overview
Multiple Allele Traits
The Concept of Multiple Allelism
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Multiple Allele Traits
The Concept of Multiple Allelism
Cholesterol: Significance and Regulation
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

